CONMED Corporation provided financial guidance for the full year 2024. The Company expects full-year 2024 reported revenue between $1.340 billion and $1.365 billion. This represents year-over-year growth of approximately 8% to 10%.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
70.34 USD | +1.35% | +0.31% | -35.77% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.77% | 2.14B | |
-4.91% | 183B | |
+0.46% | 108B | |
-3.62% | 67.51B | |
+3.26% | 50.67B | |
+9.11% | 44.7B | |
+3.26% | 40.95B | |
+6.39% | 26.8B | |
+3.83% | 26.71B | |
+14.60% | 24.62B |
- Stock Market
- Equities
- CNMD Stock
- News CONMED Corporation
- CONMED Corporation Provides Financial Guidance for the Full Year 2024